Member Directory

Autolomous enables cell & gene therapy (CGT) manufacturers to deliver personalised medicine treatments to more patients worldwide. We provide manufacturers with ways to scale their operations, by deploying a fully integrated and digitised platform, autoloMATE, which allows customers to book, make and deliver CGT treatments. Using our intuitive solutions, all types of CGTs can be made 40% more efficient while ensuring products are made more compliant, safer and cheaper.